Anteris Technologies begins U.S. enrollment in heart valve trial May 5, 2026 06:02AM
Anteris Technologies (AVR) Reiterated at Overweight by Cantor Fitzgerald: Market Strong Mar 27, 2026 07:20AM
Cantor Fitzgerald Assumes Anteris Technologies Global (AVR) at Overweight, PT $15 Mar 12, 2026 06:08AM
Wells Fargo Starts Anteris Technologies Global (AVR) at Overweight Mar 11, 2026 05:58AM
Anteris Technologies Global (AVR) files $500M mixed shelf Jan 2, 2026 05:21PM


Dec 15, 2025 06:16AM Anteris Technologies director Stephen Denaro resigns from board
Dec 1, 2025 04:46PM Anteris Technologies ends supply deal with 4C Medical
Nov 26, 2025 04:36PM Anteris Technologies Global (AVR) files for 9.1M share offering by selling stockholders
Oct 27, 2025 05:55PM Anteris Technologies begins pivotal trial for heart valve device
Oct 15, 2025 09:18AM Anteris receives European clearance for heart valve trial
Apr 21, 2025 06:42AM Cantor Fitzgerald Reiterates Overweight Rating on Anteris Technologies Global (AVR)
Mar 31, 2025 07:16AM Anteris Technologies Global (AVR) Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR THV
Mar 21, 2025 07:32AM Anteris (AVR) Reports One-Year Patient Outcomes for DurAVR THV
Mar 17, 2025 07:38AM Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer
Jan 7, 2025 06:05AM Cantor Fitzgerald Starts Anteris Technologies Global (AVR) at Overweight
Jan 7, 2025 05:32AM TD Cowen Starts Anteris Technologies Global (AVR) at Buy
Jan 7, 2025 03:29AM Barclays Starts Anteris Technologies Global (AVR) at Overweight
Dec 9, 2024 07:44AM Anteris Technologies Global Corp. (AVR) Announces Launch of U.S. Initial Public Offering
Aug 13, 2024 08:02AM Anteris Submits Confidential Draft Registration Statement for Proposed US IPO